Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01212159 · ClinicalTrials.gov registry record · Phase 4
Telephone Based Management of Hyperlipidemia
A Phase 4 study of Hyperlipidemia, sponsored by Temple University.
- Completed
- Registry status
- Phase 4
- Development phase
- 70
- Enrollment target
- 1
- Study location
NCT01212159 is a Phase 4 study of Hyperlipidemia that has completed, run by Temple University. The registered enrollment target is 70 participants, below the 406-participant average among 35 other Hyperlipidemia trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01212159, a Phase 4 study of Hyperlipidemia, has completed, sponsored by Temple University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 70 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to demonstrate that systematic self measurement of blood lipids reduces LDL cholesterol more effectively than standard care. The hypothesis is that cholesterol lowering medication adherence will be improved with self monitoring and reporting of frequent blood lipids and the percentage of patients achieving LDL goal will be greater than without home monitoring.
Conditions Studied
Interventions
- DEVICE Self Monitoring Lipid Analyzer
Study Locations (1)
Pennsylvania
- Temple University Hospital - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2010-11 |
| Est. Completion | 2015-08 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01212159
The ClinicalTrials.gov registry entry for NCT01212159 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 406-participant average among 35 other Hyperlipidemia trials with a reported enrollment target (83% lower). The listed sponsor is Temple University, which has 163 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Hyperlipidemia appearing as the primary indexed condition, and to 1 intervention - of which Self Monitoring Lipid Analyzer is the first listed.
NCT01212159 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT01212159 about?
NCT01212159 is a clinical study titled "Telephone Based Management of Hyperlipidemia". The purpose of the study is to demonstrate that systematic self measurement of blood lipids reduces LDL cholesterol more effectively than standard care. The hypothesis is that cholesterol lowering medication adherence will be improved with self monitoring and reporting of frequent blood lipids and t...
What is the current status of trial NCT01212159?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 70 participants. The study started on 2010-11. Estimated completion is 2015-08.
What conditions does trial NCT01212159 study?
This clinical trial studies the following conditions: Hyperlipidemia.
What interventions are being tested in trial NCT01212159?
The interventions under investigation include: Self Monitoring Lipid Analyzer (DEVICE).
Who is sponsoring clinical trial NCT01212159?
This trial is sponsored by Temple University, which has 163 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01212159 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hyperlipidemia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Cholesterol and Pharmacogenetic Study
COMPLETED · Phase 4
-
Colesevelam Treatment for Impaired Fasting Glucose During Niacin Therapy
COMPLETED · Phase 4
-
Targeting Metabolic Syndrome From the Emergency Department Through Mixed-Methods: Pilot Trial
RECRUITING · NA
-
Implementation of an Algorithm- and Multi-professional Team-supported Strategy to Improve Lipid Management of Patients With Atherosclerotic Cardiovascular Disease
RECRUITING · NA
-
Inspire HER: Inspiring the Heart and Emotions for Radical Health
RECRUITING · NA
-
A Clinical Study of Enlicitide in Participants With High Cholesterol (MK-0616-037)
RECRUITING · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.